37
Views
76
CrossRef citations to date
0
Altmetric
Article

Human Cancer-Associated Mutations in the Aα Subunit of Protein Phosphatase 2A Increase Lung Cancer Incidence in Aα Knock-In and Knockout Mice

, &
Pages 3832-3844 | Received 07 Jun 2011, Accepted 06 Jul 2011, Published online: 20 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (75)

Terrance J. HaanenIIIIII, Caitlin M. O'Connor & Goutham Narla. (2022) Biased holoenzyme assembly of protein phosphatase 2A (PP2A): From cancer to small molecules. Journal of Biological Chemistry 298:12, pages 102656.
Crossref
Amrita Sule, Sarah E. Golding, Syed F. Ahmad, James Watson, Mostafa H. Ahmed, Glen E. Kellogg, Tytus Bernas, Sean Koebley, Jason C. Reed, Lawrence F. Povirk & Kristoffer Valerie. (2022) ATM phosphorylates PP2A subunit A resulting in nuclear export and spatiotemporal regulation of the DNA damage response. Cellular and Molecular Life Sciences 79:12.
Crossref
Elizabeth K. Baker, Beulah Solivio, Ben Pode‐Shakked, Laura Ann Cross, Bonnie Sullivan, Annick Raas‐Rothschild, Odelia Chorin, Ortal Barel, Omer Bar‐Yosef, Ammar Husami, Robert J. Hopkin, Carlos E. Prada, Rolf W. Stottmann & Kathryn Nicole Weaver. (2022) PPP2R1A neurodevelopmental disorder is associated with congenital heart defects . American Journal of Medical Genetics Part A 188:11, pages 3262-3277.
Crossref
Tatiana Omelchenko. (2022) Cellular protrusions in 3D: Orchestrating early mouse embryogenesis. Seminars in Cell & Developmental Biology 129, pages 63-74.
Crossref
Nicola M. Sergienko, Daniel G. Donner, Lea M.D. Delbridge, Julie R. McMullen & Kate L. Weeks. (2022) Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. Cellular Signalling 91, pages 110213.
Crossref
Shen Chen, Liping Chen, Lizhu Ye, Yue Jiang, Qiong Li, Haiyan Zhang, Rui Zhang, Huiyao Li, Dianke Yu, Rong Zhang, Yujie Niu, Qun Zhao, Jianhui Liu, Gangfeng Ouyang, Michael Aschner, Yuxin Zheng, Lihua Zhang, Wen Chen & Daochuan Li. (2022) PP2A-mTOR-p70S6K/4E-BP1 axis regulates M1 polarization of pulmonary macrophages and promotes ambient particulate matter induced mouse lung injury. Journal of Hazardous Materials 424, pages 127624.
Crossref
Jin Hwa Hong, Hyun Woong Cho, Yung-Taek Ouh, Jae Kwan Lee, Yikyeong Chun & Jeong-An Gim. (2022) Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset. Journal of Gynecologic Oncology 33:3.
Crossref
Danielle Abdallah, Nipun Malhotra & Mona El Refaey. 2022. Cardiovascular Signaling in Health and Disease. Cardiovascular Signaling in Health and Disease 175 196 .
Bob Meeusen, Emanuela Elsa Cortesi, Judit Domènech Omella, Anna Sablina, Juan-Jose Ventura & Veerle Janssens. (2021) PPP2R4 dysfunction promotes KRAS-mutant lung adenocarcinoma development and mediates opposite responses to MEK and mTOR inhibition. Cancer Letters 520, pages 57-67.
Crossref
Xianming Zhou, Chao Zhang, Fei Xie, Wei Wei, Rui Li, Qian Xu, Yu Wang, Philip A. Klenotic, Goutham Narla, Nianguo Dong & Zhiyong Lin. (2021) Allosteric activation of PP2A inhibits experimental abdominal aortic aneurysm. Clinical Science 135:17, pages 2085-2097.
Crossref
Michal Slawomir Barski, Jordan James Minnell & Goedele Noella Maertens. (2021) PP2A Phosphatase as an Emerging Viral Host Factor. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Yu-Ting Yen, May Chien, Pei-Yi Wu & Shih-Chieh Hung. (2021) PP2A in LepR+ mesenchymal stem cells contributes to embryonic and postnatal endochondral ossification through Runx2 dephosphorylation. Communications Biology 4:1.
Crossref
Mufeng Du, Lin Yuan, Zhong Zhang, Cong Zhang, Minglu Zhu, Zhe Zhang, Ridong Li, Xuyang Zhao, Hui Liang, Yuhua Li, Hui Jiang, Jie Qiao & Yuxin Yin. (2021) PPP2R1B is modulated by ubiquitination and is essential for spermatogenesis. The FASEB Journal 35:5.
Crossref
Liping Chen, Ping Guo, Wenxue Li, Fei Fang, Wei Zhu, Junling Fan, Fangping Wang, Yuanyuan Gao, Qun Zhao, Qing Wang, Yongmei Xiao, Xiumei Xing, Daochuan Li, Tieliu Shi, Dianke Yu, Michael Aschner, Lihua Zhang & Wen Chen. (2021) Perturbation of Specific Signaling Pathways Is Involved in Initiation of Mouse Liver Fibrosis. Hepatology 73:4, pages 1551-1569.
Crossref
Dia Advani, Rohan Gupta, Rahul Tripathi, Sudhanshu Sharma, Rashmi K. Ambasta & Pravir Kumar. (2020) Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach. Neurochemistry International 140, pages 104841.
Crossref
Jiyeon Seo & Mikyoung Park. (2019) Molecular crosstalk between cancer and neurodegenerative diseases. Cellular and Molecular Life Sciences 77:14, pages 2659-2680.
Crossref
Nikita Panicker, Melody Coutman, Charley Lawlor-O’Neill, Richard G. S. Kahl, Séverine Roselli & Nicole M. Verrills. (2020) Ppp2r2a Knockout Mice Reveal That Protein Phosphatase 2A Regulatory Subunit, PP2A-B55α, Is an Essential Regulator of Neuronal and Epidermal Embryonic Development. Frontiers in Cell and Developmental Biology 8.
Crossref
Wen-Long Lei, Feng Han, Meng-Wen Hu, Qiu-Xia Liang, Tie-Gang Meng, Qian Zhou, Ying-Chun Ouyang, Yi Hou, Heide Schatten, Zhen-Bo Wang & Qing-Yuan Sun. (2019) Protein phosphatase 6 is a key factor regulating spermatogenesis. Cell Death & Differentiation 27:6, pages 1952-1964.
Crossref
Daniel Leonard, Wei Huang, Sudeh Izadmehr, Caitlin M. O’Connor, Danica D. Wiredja, Zhizhi Wang, Nilesh Zaware, Yinghua Chen, Daniela M. Schlatzer, Janna Kiselar, Nikhil Vasireddi, Stefan Schüchner, Abbey L. Perl, Matthew D. Galsky, Wenqing Xu, David L. Brautigan, Egon Ogris, Derek J. Taylor & Goutham Narla. (2020) Selective PP2A Enhancement through Biased Heterotrimer Stabilization. Cell 181:3, pages 688-701.e16.
Crossref
Otto Kauko, Susumu Y. Imanishi, Evgeny Kulesskiy, Laxman Yetukuri, Teemu Daniel Laajala, Mukund Sharma, Karolina Pavic, Anna Aakula, Christian Rupp, Mikael Jumppanen, Pekka Haapaniemi, Luyao Ruan, Bhagwan Yadav, Veronika Suni, Taru Varila, Garry L. Corthals, Jüri Reimand, Krister Wennerberg, Tero Aittokallio & Jukka Westermarck. (2020) Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1. Journal of Biological Chemistry 295:13, pages 4194-4211.
Crossref
Caitlin M. O’Connor, Daniel Leonard, Danica Wiredja, Rita A. Avelar, Zhizhi Wang, Daniela Schlatzer, Benjamin Bryson, Eesha Tokala, Sarah E. Taylor, Aditya Upadhyay, Jaya Sangodkar, Anne-Claude Gingras, Jukka Westermarck, Wenqing Xu, Analisa DiFeo, David L. Brautigan, Shozeb Haider, Mark Jackson & Goutham Narla. (2019) Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors. Oncogene 39:3, pages 703-717.
Crossref
Cassandra P. Nader, Aylin Cidem, Nicole M. Verrills & Alaina J. Ammit. (2019) Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer. Respiratory Research 20:1.
Crossref
Deepika Raman & Shazib Pervaiz. (2019) Redox inhibition of protein phosphatase PP2A: Potential implications in oncogenesis and its progression. Redox Biology 27, pages 101105.
Crossref
Andrew R. Clark & Michael Ohlmeyer. (2019) Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration. Pharmacology & Therapeutics 201, pages 181-201.
Crossref
Meghna Kataria & Hiroyuki Yamano. (2019) Interplay between Phosphatases and the Anaphase-Promoting Complex/Cyclosome in Mitosis. Cells 8:8, pages 814.
Crossref
Ying Ding, Aixin Yu, George C. Tsokos & Thomas R. Malek. (2019) CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells. The Journal of Immunology 203:1, pages 93-104.
Crossref
Michiel Remmerie & Veerle Janssens. (2019) PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer. Frontiers in Oncology 9.
Crossref
Caitlin M. O'Connor, Matthew T. Hoffa, Sarah E. Taylor, Rita A. Avelar & Goutham Narla. (2019) Protein phosphatase 2A Aα regulates Aβ protein expression and stability. Journal of Biological Chemistry 294:15, pages 5923-5934.
Crossref
Sara Reynhout & Veerle Janssens. (2019) Physiologic functions of PP2A: Lessons from genetically modified mice. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1866:1, pages 31-50.
Crossref
Sara Reynhout, Sandra Jansen, Dorien Haesen, Siska van Belle, Sonja A. de Munnik, Ernie M.H.F. Bongers, Jolanda H. Schieving, Carlo Marcelis, Jeanne Amiel, Marlène Rio, Heather Mclaughlin, Roger Ladda, Susan Sell, Marjolein Kriek, Cacha M.P.C.D. Peeters-Scholte, Paulien A. Terhal, Koen L. van Gassen, Nienke Verbeek, Sonja Henry, Jessica Scott Schwoerer, Saleem Malik, Nicole Revencu, Carlos R. Ferreira, Ellen Macnamara, Hilde M.H. Braakman, Elise Brimble, Maura R.Z. Ruzhnikov, Matias Wagner, Philip Harrer, Dagmar Wieczorek, Alma Kuechler, Barak Tziperman, Ortal Barel, Bert B.A. de Vries, Christopher T. Gordon, Veerle Janssens & Lisenka E.L.M. Vissers. (2019) De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders. The American Journal of Human Genetics 104:1, pages 139-156.
Crossref
Holly Fowle, Ziran Zhao & Xavier Graña. 2019. 55 93 .
Scott P. Lyons, Nicole P. Jenkins, Isha Nasa, Meng S. Choy, Mark E. Adamo, Rebecca Page, Wolfgang Peti, Greg B. Moorhead & Arminja N. Kettenbach. (2018) A Quantitative Chemical Proteomic Strategy for Profiling Phosphoprotein Phosphatases from Yeast to Humans. Molecular & Cellular Proteomics 17:12, pages 2448-2461.
Crossref
Michiel Remmerie & Veerle Janssens. (2018) Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late. International Journal of Molecular Sciences 19:8, pages 2380.
Crossref
Otto Kauko, Caitlin M. O’ConnorEvgeny KulesskiyJaya SangodkarAnna AakulaSudeh IzadmehrLaxman Yetukuri, Bhagwan Yadav, Artur Padzik, Teemu Daniel Laajala, Pekka HaapaniemiMajid Momeny, Taru Varila, Michael OhlmeyerTero Aittokallio, Krister WennerbergGoutham NarlaJukka Westermarck. (2018) PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells. Science Translational Medicine 10:450.
Crossref
Gang Xiao, Lai N. Chan, Lars Klemm, Daniel Braas, Zhengshan Chen, Huimin Geng, Qiuyi Chen Zhang, Ali Aghajanirefah, Kadriye Nehir Cosgun, Teresa Sadras, Jaewoong Lee, Tamara Mirzapoiazova, Ravi Salgia, Thomas Ernst, Andreas Hochhaus, Hassan Jumaa, Xiaoyan Jiang, David M. Weinstock, Thomas G. Graeber & Markus Müschen. (2018) B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies. Cell 173:2, pages 470-484.e18.
Crossref
Otto Kauko & Jukka Westermarck. (2018) Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer. The International Journal of Biochemistry & Cell Biology 96, pages 157-164.
Crossref
Caitlin M. O’Connor, Abbey Perl, Daniel Leonard, Jaya Sangodkar & Goutham Narla. (2018) Therapeutic targeting of PP2A. The International Journal of Biochemistry & Cell Biology 96, pages 182-193.
Crossref
Bob Meeusen & Veerle Janssens. (2018) Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification. The International Journal of Biochemistry & Cell Biology 96, pages 98-134.
Crossref
Ammaji Rajala, Yuhong Wang, Steven F. Abcouwer, Thomas W. Gardner & Raju V.S. Rajala. (2017) Developmental and light regulation of tumor suppressor protein PP2A in the retina. Oncotarget 9:2, pages 1505-1523.
Crossref
C Lambrecht, L Libbrecht, X Sagaert, P Pauwels, Y Hoorne, J Crowther, J V Louis, W Sents, A Sablina & V Janssens. (2017) Loss of protein phosphatase 2A regulatory subunit B56δ promotes spontaneous tumorigenesis in vivo. Oncogene 37:4, pages 544-552.
Crossref
Alexander V. Kolesnikov, Tivadar OrbanHui JinCeline BrooksLukas HofmannZhiqian Dong, Maxim SokolovKrzysztof Palczewski & Vladimir J. Kefalov. (2017) Dephosphorylation by protein phosphatase 2A regulates visual pigment regeneration and the dark adaptation of mammalian photoreceptors. Proceedings of the National Academy of Sciences 114:45.
Crossref
Lauren F. Watt, Nikita Panicker, Abdul Mannan, Ben Copeland, Richard G. S. Kahl, Matthew D. Dun, Barbara Young, Severine Roselli & Nicole M. Verrills. (2017) Functional importance of PP2A regulatory subunit loss in breast cancer. Breast Cancer Research and Treatment 166:1, pages 117-131.
Crossref
Shawn Baldacchino, Laura M Wastall, Christian Saliba, Thomas A Hughes, Christian Scerri, Angelene Berwick, Valerie Speirs, Andrew M Hanby & Godfrey Grech. (2017) CIP2A expression predicts recurrences of tamoxifen-treated breast cancer. Tumor Biology 39:10, pages 101042831772206.
Crossref
Hila Shomin-Levi & Oded Yarden. (2017) The Neurospora crassa PP2A Regulatory Subunits RGB1 and B56 Are Required for Proper Growth and Development and Interact with the NDR Kinase COT1. Frontiers in Microbiology 8.
Crossref
Hanying Wang, Kailun Xu, Beilei Wang, Jinghui Liu, Xiaofeng Wang, Mingluan Xing, Pu Huang, Zonglou Guo & Lihong Xu. (2017) Microcystin-LR induces a wide variety of biochemical changes in the A549 human non-small cell lung cancer cell line: Roles for protein phosphatase 2A and its substrates. Environmental Toxicology 32:3, pages 1065-1078.
Crossref
Meng-Wen Hu, Tie-Gang Meng, Zong-Zhe Jiang, Ming-Zhe Dong, Heide Schatten, Xingzhi Xu, Zhen-Bo Wang & Qing-Yuan Sun. (2016) Protein Phosphatase 6 Protects Prophase I-Arrested Oocytes by Safeguarding Genomic Integrity. PLOS Genetics 12:12, pages e1006513.
Crossref
Peter P. Ruvolo. (2016) The broken “Off” switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance. BBA Clinical 6, pages 87-99.
Crossref
Dorien Haesen, Layka Abbasi Asbagh, Rita Derua, Antoine Hubert, Stefanie Schrauwen, Yana Hoorne, Frédéric Amant, Etienne Waelkens, Anna Sablina & Veerle Janssens. (2016) Recurrent PPP2R1A Mutations in Uterine Cancer Act through a Dominant-Negative Mechanism to Promote Malignant Cell Growth . Cancer Research 76:19, pages 5719-5731.
Crossref
Godfrey Grech, Shawn Baldacchino, Christian Saliba, Maria Pia Grixti, Robert Gauci, Vanessa Petroni, Anthony G. Fenech & Christian Scerri. (2016) Deregulation of the protein phosphatase 2A, PP2A in cancer: complexity and therapeutic options. Tumor Biology 37:9, pages 11691-11700.
Crossref
Amanda M. Smith, Matthew D. Dun, Erwin M. Lee, Celeste Harrison, Richard Kahl, Hayley Flanagan, Nikita Panicker, Baratali Mashkani, Anthony S. Don, Jonathan Morris, Hamish Toop, Richard B. Lock, Jason A. Powell, Daniel Thomas, Mark A. Guthridge, Andrew Moore, Leonie K. Ashman, Kathryn A. Skelding, Anoop Enjeti & Nicole M. Verrills. (2016) Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors. Oncotarget 7:30, pages 47465-47478.
Crossref
Sokratis A Apostolidis, Noé Rodríguez-Rodríguez, Abel Suárez-Fueyo, Nikolina Dioufa, Esra Ozcan, José C Crispín, Maria G Tsokos & George C Tsokos. (2016) Phosphatase PP2A is requisite for the function of regulatory T cells. Nature Immunology 17:5, pages 556-564.
Crossref
Ashley L. Hein, Parthasarathy Seshacharyulu, Satyanarayana Rachagani, Yuri M. Sheinin, Michel M. Ouellette, Moorthy P. Ponnusamy, Marc C. Mumby, Surinder K. Batra & Ying Yan. (2016) PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling. Cancer Research 76:8, pages 2243-2253.
Crossref
Jaya Sangodkar, Caroline C. Farrington, Kimberly McClinch, Matthew D. Galsky, David B. Kastrinsky & Goutham Narla. (2016) All roads lead to PP2A: exploiting the therapeutic potential of this phosphatase. FEBS Journal 283:6, pages 1004-1024.
Crossref
Ira K. Gordon, Jie Lu, Christian A. Graves, Kristin Huntoon, Jason M. Frerich, Ryan H. Hanson, Xiaoping Wang, Christopher S. Hong, Winson Ho, Michael J. Feldman, Barbara Ikejiri, Kheem Bisht, Xiaoyuan S. Chen, Anita Tandle, Chunzhang Yang, W. Tristram Arscott, Donald Ye, John D. Heiss, Russell R. Lonser, Kevin Camphausen & Zhengping Zhuang. (2015) Protein Phosphatase 2A Inhibition with LB100 Enhances Radiation-Induced Mitotic Catastrophe and Tumor Growth Delay in Glioblastoma. Molecular Cancer Therapeutics 14:7, pages 1540-1547.
Crossref
Hao Liu, Yixue Gu, Hongsheng Wang, Jiang Yin, Guopei Zheng, Zhijie Zhang, Minyin Lu, Chenkun Wang & Zhimin He. (2015) Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer. Oncotarget 6:17, pages 14913-14925.
Crossref
Maeve Kiely & Patrick Kiely. (2015) PP2A: The Wolf in Sheep’s Clothing?. Cancers 7:2, pages 648-669.
Crossref
Xiaoyun Pan, Xia Chen, Xin Tong, Chao Tang & Jianmin Li. (2015) Ppp2ca knockout in mice spermatogenesis. REPRODUCTION 149:4, pages 385-391.
Crossref
Dawn R. Christianson, Andrey S. DobroffBettina Proneth, Amado J. Zurita, Ahmad Salameh, Eleonora Dondossola, Jun Makino, Cristian G. Bologa, Tracey L. SmithVirginia J. YaoTiffany L. CalderoneDavid J. O'Connell, Tudor I. Oprea, Kazunori KataokaDolores J. Cahill, Jeffrey E. GershenwaldRichard L. Sidman, Wadih ArapRenata Pasqualini. (2015) Ligand-directed targeting of lymphatic vessels uncovers mechanistic insights in melanoma metastasis. Proceedings of the National Academy of Sciences 112:8, pages 2521-2526.
Crossref
Meng-Wen Hu, Zhen-Bo Wang, Yan Teng, Zong-Zhe Jiang, Xue-Shan Ma, Ning Hou, Xuan Cheng, Heide Schatten, Xingzhi Xu, Xiao Yang & Qing-Yuan Sun. (2015) Loss of protein phosphatase 6 in oocytes causes failure of meiosis II exit and impaired female fertility. Journal of Cell Science.
Crossref
Dorien Haesen, Ward Sents, Katleen Lemaire, Yana Hoorne & Veerle Janssens. (2014) The Basic Biology of PP2A in Hematologic Cells and Malignancies. Frontiers in Oncology 4.
Crossref
Shawn Baldacchino, Christian Saliba, Vanessa Petroni, Anthony G Fenech, Nigel Borg & Godfrey Grech. (2014) Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720. EPMA Journal 5:1.
Crossref
CATHRINE LILLO, AMR R. A. KATAYA, BEHZAD HEIDARI, MARIA T. CREIGHTON, DUGASSA NEMIE‐FEYISSA, ZEKARIAS GINBOT & ELSE M. JONASSEN. (2014) Protein phosphatases PP 2A, PP 4 and PP 6: mediators and regulators in development and responses to environmental cues . Plant, Cell & Environment 37:12, pages 2631-2648.
Crossref
Xueli Bai, Xiao Zhi, Qi Zhang, Feng Liang, Wei Chen, Chao Liang, Qida Hu, Xu Sun, Zhengping Zhuang & Tingbo Liang. (2014) Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis. Cancer Letters 355:2, pages 281-287.
Crossref
Peng Lv, Yue Wang, Jie Ma, Zheng Wang, Jing-Li Li, Christopher S. Hong, Zhengping Zhuang & Yi-Xin Zeng. (2014) Inhibition of protein phosphatase 2A with a small molecule LB100 radiosensitizes nasopharyngeal carcinoma xenografts by inducing mitotic catastrophe and blocking DNA damage repair. Oncotarget 5:17, pages 7512-7524.
Crossref
Johannes Linxweiler, Laxmikanth Kollipara, René P. Zahedi, Pavel Lampel, Richard Zimmermann & Markus Greiner. (2014) Proteomic insights into non-small cell lung cancer: New ideas for cancer diagnosis and therapy from a functional viewpoint. EuPA Open Proteomics 4, pages 25-39.
Crossref
Meng-Wen Hu, Zhen-Bo Wang, Zong-Zhe Jiang, Shu-Tao Qi, Lin Huang, Qiu-Xia Liang, Heide Schatten & Qing-Yuan Sun. (2014) Scaffold Subunit Aalpha of PP2A Is Essential for Female Meiosis and Fertility in Mice1. Biology of Reproduction 91:1.
Crossref
Parthasarathy Seshacharyulu, Poomy Pandey, Kaustubh Datta & Surinder K. Batra. (2013) Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Letters 335:1, pages 9-18.
Crossref
Kennen B. MacKay, Yiping Tu, Stephen G. Young & Steven G. Clarke. (2013) Circumventing Embryonic Lethality with Lcmt1 Deficiency: Generation of Hypomorphic Lcmt1 Mice with Reduced Protein Phosphatase 2A Methyltransferase Expression and Defects in Insulin Signaling. PLoS ONE 8:6, pages e65967.
Crossref
P Pandey, P Seshacharyulu, S Das, S Rachagani, M P Ponnusamy, Y Yan, S L Johansson, K Datta, M Fong Lin & S K Batra. (2013) Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway. British Journal of Cancer 108:12, pages 2590-2600.
Crossref
Danilo Perrotti & Paolo Neviani. (2013) Protein phosphatase 2A: a target for anticancer therapy. The Lancet Oncology 14:6, pages e229-e238.
Crossref
David L. Brautigan. (2013) Protein Ser/ Thr phosphatases - the ugly ducklings of cell signalling. FEBS Journal 280:2, pages 324-325.
Crossref
Ward Sents, Elitsa Ivanova, Caroline Lambrecht, Dorien Haesen & Veerle Janssens. (2013) The biogenesis of active protein phosphatase 2A holoenzymes: a tightly regulated process creating phosphatase specificity. FEBS Journal 280:2, pages 644-661.
Crossref
Emily A. Foley & Tarun M. Kapoor. (2012) Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nature Reviews Molecular Cell Biology 14:1, pages 25-37.
Crossref
Caroline Lambrecht, Dorien Haesen, Ward Sents, Elitsa Ivanova & Veerle Janssens. 2013. Phosphatase Modulators. Phosphatase Modulators 283 305 .
Meir Shamay, Jianyong Liu, Renfeng Li, Gangling Liao, Li Shen, Melanie Greenway, Shaohui Hu, Jian Zhu, Zhi Xie, Richard F. Ambinder, Jiang Qian, Heng Zhu & S. Diane Hayward. (2012) A Protein Array Screen for Kaposi's Sarcoma-Associated Herpesvirus LANA Interactors Links LANA to TIP60, PP2A Activity, and Telomere Shortening. Journal of Virology 86:9, pages 5179-5191.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.